|
?:abstract
|
-
Objective: to collect and confirm the scientific information available regarding SARS-CoV-2 during the gestational process and its effects on the obstetric patient during delivery and puerperium, and on the newborn Method: a bibliographic review of the evidence available was conducted in three international databases: PubMed, Science Direct and Cochrane Standardized terms were used, as well as free language, synonyms and truncation, combining them with Boolean operators based on the capacity of each database Likewise, the webpages of official organizations and scientific societies addressing the matter of pregnancy and COVID-19 were also consulted Results: in total, 14 articles and 9 clinical practice guidelines were selected, as well as technical reports from different national and international organizations There is limited bibliography, and with low scientific evidence, given the novelty of the pandemic caused by this coronavirus, but scientific documents were retrieved which addressed pregnancy and fetus, delivery, puerperium and newborns It is believed that the SARS-CoV-2 virus has less adverse reactions in the pregnant woman and her newborn than other viruses from the same class Each pregnant woman infected and her newborn should be subject to early identification and evaluation, in an individual and multidisciplinary way in order to prevent adverse results and complications There is no evidence of the vertical transmission of the SARS-CoV-2 virus There are discrepancies regarding the management of newborns of pregnant women infected by COVID-19 Conclusion: there are many knowledge gaps regarding the management of pregnant women, delivery, puerperium and newborns, because there is limited evidence available © 2020 DAE Editorial, Grupo Paradigma All rights reserved
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}